نتائج البحث - "George Wilding"

1

Supplementary Figures 1 - 4, Table 1 from Real-Time Immune Monitoring to Guide Plasmid DNA Vaccination Schedule Targeting Prostatic Acid Phosphatase in Patients with Castration-Resistant Prostate Cancer

المؤلفون: Brian M. Olson, George Wilding, Glenn Liu, Mary Jane Staab, Isabel Pohlkamp, Eric Bradley, Laura E. Johnson, Jens C. Eickhoff, Jordan T. Becker, Douglas G. McNeel

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dba0c060ade5ef364baa3e39b4e27d4
https://doi.org/10.1158/1078-0432.22454915

View record in OpenAIRE

2

Supplemental Figure Legend from Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement

المؤلفون: J. Jack Lee, George Wilding, Aman Buzdar, James C. Yao, David S. Hong, Suzanne E. Davis, Jun Weng, Mellanie Price, Steven I. Sherman, Chad Tang

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a104c8b521082b6ddebe2b9f1263e10a
https://doi.org/10.1158/1078-0432.22464287.v1

View record in OpenAIRE

3

Data from Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805

المؤلفون: Robert S. DiPaola, George Wilding, Janice J. Dutcher, Michael B. Atkins, Christopher G. Wood, Lori Wood, Michael Jewett, Christopher J. Kane, Robert G. Uzzo, Keith T. Flaherty, Bonnie Ky, Judith Manola, Naomi B. Haas

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12fa09c296f419eebfab4d0db0d4e58a
https://doi.org/10.1158/1078-0432.c.6523328

View record in OpenAIRE

4

Supplementary Figure from Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805

المؤلفون: Robert S. DiPaola, George Wilding, Janice J. Dutcher, Michael B. Atkins, Christopher G. Wood, Lori Wood, Michael Jewett, Christopher J. Kane, Robert G. Uzzo, Keith T. Flaherty, Bonnie Ky, Judith Manola, Naomi B. Haas

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e36a0b8b6222573111696e2deb5fe2b
https://doi.org/10.1158/1078-0432.22456487.v1

View record in OpenAIRE

5

Supplementary Figure Legends, Table Legend from Real-Time Immune Monitoring to Guide Plasmid DNA Vaccination Schedule Targeting Prostatic Acid Phosphatase in Patients with Castration-Resistant Prostate Cancer

المؤلفون: Brian M. Olson, George Wilding, Glenn Liu, Mary Jane Staab, Isabel Pohlkamp, Eric Bradley, Laura E. Johnson, Jens C. Eickhoff, Jordan T. Becker, Douglas G. McNeel

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::406f899319be29bdb0fa87cd2b86c297
https://doi.org/10.1158/1078-0432.22454918

View record in OpenAIRE

6

Supplemental Figure 1 from Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement

المؤلفون: J. Jack Lee, George Wilding, Aman Buzdar, James C. Yao, David S. Hong, Suzanne E. Davis, Jun Weng, Mellanie Price, Steven I. Sherman, Chad Tang

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0630d5594a23560ef3ffcefbd35cf825
https://doi.org/10.1158/1078-0432.22464293.v1

View record in OpenAIRE

7

Supplemental Figure 2 from Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement

المؤلفون: J. Jack Lee, George Wilding, Aman Buzdar, James C. Yao, David S. Hong, Suzanne E. Davis, Jun Weng, Mellanie Price, Steven I. Sherman, Chad Tang

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f37fffcae8ff3acda723ab2609e8fca
https://doi.org/10.1158/1078-0432.22464290

View record in OpenAIRE

8

Data from Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement

المؤلفون: J. Jack Lee, George Wilding, Aman Buzdar, James C. Yao, David S. Hong, Suzanne E. Davis, Jun Weng, Mellanie Price, Steven I. Sherman, Chad Tang

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a491c5605c974de630bcf195b3fdc51
https://doi.org/10.1158/1078-0432.c.6525668.v1

View record in OpenAIRE

9

Data from Real-Time Immune Monitoring to Guide Plasmid DNA Vaccination Schedule Targeting Prostatic Acid Phosphatase in Patients with Castration-Resistant Prostate Cancer

المؤلفون: Brian M. Olson, George Wilding, Glenn Liu, Mary Jane Staab, Isabel Pohlkamp, Eric Bradley, Laura E. Johnson, Jens C. Eickhoff, Jordan T. Becker, Douglas G. McNeel

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02934f1a197e2fa5a22b5b00680ec781
https://doi.org/10.1158/1078-0432.c.6522872

View record in OpenAIRE

10

Supplementary Tables 1-5, Figures 1-3 from Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805

المؤلفون: Robert S. DiPaola, George Wilding, Janice J. Dutcher, Michael B. Atkins, Christopher G. Wood, Lori Wood, Michael Jewett, Christopher J. Kane, Robert G. Uzzo, Keith T. Flaherty, Bonnie Ky, Judith Manola, Naomi B. Haas

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48928bf28fff5fc4f473444725ebe2f6
https://doi.org/10.1158/1078-0432.22456484.v1

View record in OpenAIRE

11

Supplemental Table 1-2 from Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement

المؤلفون: J. Jack Lee, George Wilding, Aman Buzdar, James C. Yao, David S. Hong, Suzanne E. Davis, Jun Weng, Mellanie Price, Steven I. Sherman, Chad Tang

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73f616332ac44d1e092e10669cc3a705
https://doi.org/10.1158/1078-0432.22464284

View record in OpenAIRE

12

Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network–Based Artificial Intelligence Tool

المؤلفون: Savitri Krishnamurthy, Parag Jain, Debu Tripathy, Roland Basset, Ramandeep Randhawa, Hassan Muhammad, Wei Huang, Hua Yang, Shivaani Kummar, George Wilding, Rajat Roy

المصدر: JCO Clinical Cancer Informatics.

مصطلحات موضوعية: General Medicine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::35851f427a4a3e339038a697a37d19b6
https://doi.org/10.1200/cci.22.00181

View record in OpenAIRE

13

A Novel Artificial Intelligence–Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers

المؤلفون: Wei Huang, Ramandeep Randhawa, Parag Jain, Samuel Hubbard, Jens Eickhoff, Shivaani Kummar, George Wilding, Hirak Basu, Rajat Roy

المصدر: JCO Clin Cancer Inform

مصطلحات موضوعية: Male, Prostatectomy, Artificial Intelligence, Prostate, Humans, Prostatic Neoplasms, ORIGINAL REPORTS, General Medicine, Prostate-Specific Antigen

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::403dfab88aa713628a412ee9966ef5b3
https://doi.org/10.1200/cci.21.00131

View record in OpenAIRE

14

Abstract 5408: AI powered-platform to predict gene modifications from prostate and breast cancer whole slide images

المؤلفون: Wei Huang, Parag Jain, Chensu Xie, Hassan Muhammad, Hirak Basu, George Wilding, Rajat Roy

المصدر: Cancer Research. 83:5408-5408

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f8646fd8b6806103d6a08294d20d824c
https://doi.org/10.1158/1538-7445.am2023-5408

View record in OpenAIRE

15

Abstract P6-01-18: Predicting response of triple negative breast cancer to neoadjuvant chemotherapy using a deep convolutional neural network-based artificial intelligence tool

المؤلفون: Savitri Krishnamurthy, Parag Jain, Debu Tripathy, Hassan Muhammad, Wei huang, Hua Yang, Shivaani Kummar, George Wilding, Rajat Roy, Ramandeep Randhawa

المصدر: Cancer Research. 83:P6-01

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::70ebf9b3a715162077e18cf12ed078dd
https://doi.org/10.1158/1538-7445.sabcs22-p6-01-18

View record in OpenAIRE

16

Prostate cancer cells survive anti-androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities

المؤلفون: Lianchun Xiao, George Wilding, Amado J. Zurita, Hirak Basu, James M. Reuben, Mark Titus, Samantha Robertson, Sumankalai Ramachandran, Evan N. Cohen, Nathaniel Wilganowski

المصدر: The ProstateREFERENCES. 81(12)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4462e59d560ef4d64c7561c9696abdd
https://pubmed.ncbi.nlm.nih.gov/34170017

View record in OpenAIRE

17

Abstract 2357: Inhibition of CDK8/19 mediator kinase suppresses primary and metastatic growth of castration-resistant prostate cancer

المؤلفون: Jing Li, Thomas Hilimire, Chen Cheng, Eugenia V. Broude, Yueying Liu, Michael B. Lilly, Yusuke Shiozawa, George Wilding, Igor B. Roninson, Mengqian Chen

المصدر: Cancer Research. 82:2357-2357

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7f24b876e99d52b499fd296af498fdab
https://doi.org/10.1158/1538-7445.am2022-2357

View record in OpenAIRE

18

Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial

المؤلفون: David Cella, Michael J. Volk, Judith Manola, Michael A. Carducci, Gary R. Hudes, Yu-Ning Wong, Judd W. Moul, Bruce J. Roth, Richard Scher, Michael J. Fisch, Andrea M. Barsevick, Stephen D. Williams, David J. Vaughn, George Wilding

المصدر: Clinical Genitourinary Cancer. 16:e315-e322

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8c25a4c05698d5ec032879573d5282ab
https://doi.org/10.1016/j.clgc.2017.10.001

View record in OpenAIRE

19

Academic Journal

Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy.' Cancer Chemotherapy & Pharmacology 65(4

المؤلفون: Noelle K Loconte, Maureen Smith, Dona Alberti, Jevrey Bozeman, James F Cleary, Ashley N Setala, Geov Wodtke, George Wilding, Kyle D Holen

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: http://gtwodtke.com/wp-content/mydocs/LoConte_2010_Age_comorbidity_dose-limiting_toxicity.pdf.

وصف الملف: application/pdf

Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1074.5175; http://gtwodtke.com/wp-content/mydocs/LoConte_2010_Age_comorbidity_dose-limiting_toxicity.pdf

الاتاحة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1074.5175
http://gtwodtke.com/wp-content/mydocs/LoConte_2010_Age_comorbidity_dose-limiting_toxicity.pdf

View record in BASE

20

Academic Journal

General Hospital Cancer Center

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: https://mywebspace.wisc.edu/lbjohnson2/Journal Club Website/Articles/Motzer_et_al-Sunitinib_and_RCC.pdf.

وصف الملف: application/pdf

Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.629.9756

الاتاحة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.629.9756

View record in BASE

تنقيح النتائج